Kliniske studier indikerer, at multipel sklerose- patienter kan modtage Rebif og kortikosteroider eller ACTH under et recidiv.
Clinical studies indicate that multiple sclerosis patients can receive Rebif and corticosteroids or ACTH during relapses.